The Potential Treatment Options and Combination Strategies of KRAS-Mutated Lung Cancer
OncoTargets and Therapy · 2024-11 · Volume 17 · 1041-1057
DOI: 10.2147/ott.s484209 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift OncoTargets and Therapy, 2024-11. Verfasst von Xinchao Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, People's Republic of China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, People's Republic of China.
Zitieren
APA
Zhao, X., Zheng, Y., Wang, Y., Zhang, M., Dong, Z., Liu, Y., & Sun, M. (2024). The Potential Treatment Options and Combination Strategies of KRAS-Mutated Lung Cancer. OncoTargets and Therapy, Volume 17, 1041-1057. https://doi.org/10.2147/ott.s484209
Vancouver
Zhao X, Zheng Y, Wang Y, Zhang M, Dong Z, Liu Y, et al. The Potential Treatment Options and Combination Strategies of KRAS-Mutated Lung Cancer. OncoTargets and Therapy. 2024;Volume 17:1041-1057. doi:10.2147/ott.s484209
BibTeX
@article{Zhao2024,
author = {Zhao, Xinchao and Zheng, Yawen and Wang, Yufeng and Zhang, Mingyan and Dong, Zhilin and Liu, Yanan and Sun, Meili},
title = {The Potential Treatment Options and Combination Strategies of KRAS-Mutated Lung Cancer},
journal = {OncoTargets and Therapy},
year = {2024},
volume = {Volume 17},
pages = {1041--1057},
doi = {10.2147/ott.s484209}
}
EUVIMED